BioCardia, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
BioCardia, Inc. (BCDA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.90 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-14
- BioCardia, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$1.83M.
- BioCardia, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$64.00K.
- BioCardia, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $18.92M.
- BioCardia, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$125.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|
| 2017-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$1.90M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$64.00K 10-Q · filed 2017-05-11 | ||
| 2016-12-31 | $18.92M 10-K · filed 2017-03-30 | ||
| 2015-12-31 | -$125.00K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |